{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:55:46Z","timestamp":1791291346053,"version":"4.3.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","award":["YDZJ202401684ZYTS"],"award-info":[{"award-number":["YDZJ202401684ZYTS"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This systematic review and meta-analysis aimed to compare the associations of four triglyceride-glucose (TyG)-derived indices (TyG, TyG-BMI, TyG-WC, TyG-WHtR) with incident cardiovascular disease (CVD) risk among individuals with stage 0\u20133 cardio-kidney-metabolic (CKM) syndrome, and explore potential sources of inter-study heterogeneity using pre-specified subgroup analyses and exploratory meta-regression analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We systematically searched PubMed, Embase, Web of Science, and the Cochrane Library from database inception to May 1, 2026. Two independent reviewers completed study screening, data extraction, and quality assessment using the Newcastle\u2013Ottawa Scale (NOS). Pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were synthesized using fixed- or random-effects models according to between-study heterogeneity, which was quantified by Cochran\u2019s Q test and the I\u00b2 statistic. Subgroup analyses, exploratory univariable meta-regression analyses, leave-one-out sensitivity analyses, and publication bias assessments were performed to investigate potential sources of heterogeneity and evaluate the robustness of the findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nine high-quality prospective cohort studies were ultimately included. Participants in the highest versus lowest quantiles of each index had significantly elevated CVD risk: TyG (HR\u2009=\u20091.24, 95% CI 1.16\u20131.33, I\u00b2 = 76%), TyG-BMI (HR\u2009=\u20091.44, 95% CI 1.26\u20131.66, I\u00b2 = 93%), TyG-WC (HR\u2009=\u20091.42, 95% CI 1.21\u20131.67, I\u00b2 = 96%), and TyG-WHtR (HR\u2009=\u20091.45, 95% CI 1.28\u20131.65, I\u00b2 = 91%). Exploratory meta-regression suggested that follow-up duration may contribute to heterogeneity in TyG, whereas age may contribute to heterogeneity in TyG-WHtR; substantial residual heterogeneity remained for TyG-WC and TyG-WHtR. Sensitivity analyses supported the robustness of the findings. No significant publication bias was detected, but statistical power was limited by fewer than 10 studies per index.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This meta-analysis suggests that elevated TyG-derived indices are significantly associated with increased incident CVD risk among individuals with stage 0\u20133 CKM syndrome. Composite TyG-derived indices showed numerically higher pooled effect estimates than the TyG index; however, overlapping confidence intervals and the absence of direct statistical comparisons prevent conclusions regarding the superiority of any specific index. Given the observational nature of the included studies, limited population diversity, and substantial residual heterogeneity, these findings should be interpreted cautiously. TyG-derived indices may represent potential auxiliary markers for CVD risk stratification, and further large-scale multi-ethnic prospective studies are warranted to evaluate their clinical utility.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-026-06534-w","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:47:01Z","timestamp":1787766421000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between triglyceride-glucose-related indices and cardiovascular disease risk in population with cardio-kidney-metabolic syndrome stages 0\u20133: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Yanxu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenru","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hezeng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghai","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"issue":"20","key":"6534_CR1","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, Coresh J, Mathew RO, Baker-Smith CM, Carnethon MR, et al. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association. Circulation. 2023;148(20):1606\u201335.","journal-title":"Circulation"},{"issue":"20","key":"6534_CR2","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, Coresh J, Baker-Smith CM, Carnethon MR, Despr\u00e9s JP, et al. A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association. Circulation. 2023;148(20):1636\u201364.","journal-title":"Circulation"},{"issue":"7","key":"6534_CR3","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.jacasi.2025.04.007","volume":"5","author":"C Zheng","year":"2025","unstructured":"Zheng C, Cai A, Sun M, Wang X, Song Q, Pei X, Cao X, Tian Y, Lip GYH, Parati G, et al. Prevalence and Mortality of Cardiovascular-Kidney-Metabolic Syndrome in China: A Nationwide Population-Based Study. JACC Asia. 2025;5(7):898\u2013910.","journal-title":"JACC Asia"},{"issue":"24","key":"6534_CR4","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","volume":"148","author":"SS Khan","year":"2023","unstructured":"Khan SS, Coresh J, Pencina MJ, Ndumele CE, Rangaswami J, Chow SL, Palaniappan LP, Sperling LS, Virani SS, Ho JE, et al. Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association. Circulation. 2023;148(24):1982\u20132004.","journal-title":"Circulation"},{"issue":"1","key":"6534_CR5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12933-024-02244-9","volume":"23","author":"C Cui","year":"2024","unstructured":"Cui C, Liu L, Qi Y, Han N, Xu H, Wang Z, Shang X, Han T, Zha Y, Wei X, et al. Joint association of TyG index and high sensitivity C-reactive protein with cardiovascular disease: a national cohort study. Cardiovasc Diabetol. 2024;23(1):156.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"6534_CR6","doi-asserted-by":"publisher","first-page":"e0212963","DOI":"10.1371\/journal.pone.0212963","volume":"14","author":"J Lim","year":"2019","unstructured":"Lim J, Kim J, Koo SH, Kwon GC. Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: An analysis of the 2007\u20132010 Korean National Health and Nutrition Examination Survey. PLoS ONE. 2019;14(3):e0212963.","journal-title":"PLoS ONE"},{"issue":"1","key":"6534_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12933-024-02572-w","volume":"24","author":"Y Qiao","year":"2025","unstructured":"Qiao Y, Wang Y, Chen C, Huang Y, Zhao C. Association between triglyceride-glucose (TyG) related indices and cardiovascular diseases and mortality among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study of UK Biobank. Cardiovasc Diabetol. 2025;24(1):12.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"6534_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12933-023-01906-4","volume":"22","author":"S Liang","year":"2023","unstructured":"Liang S, Wang C, Zhang J, Liu Z, Bai Y, Chen Z, Huang H, He Y. Triglyceride-glucose index and coronary artery disease: a systematic review and meta-analysis of risk, severity, and prognosis. Cardiovasc Diabetol. 2023;22(1):170.","journal-title":"Cardiovasc Diabetol"},{"key":"6534_CR9","doi-asserted-by":"publisher","first-page":"951689","DOI":"10.3389\/fendo.2022.951689","volume":"13","author":"Y Xue","year":"2022","unstructured":"Xue Y, Xu J, Li M, Gao Y. Potential screening indicators for early diagnosis of NAFLD\/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters. Front Endocrinol. 2022;13:951689.","journal-title":"Front Endocrinol"},{"issue":"1","key":"6534_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","volume":"21","author":"LC Tao","year":"2022","unstructured":"Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.","journal-title":"Cardiovasc Diabetol"},{"key":"6534_CR11","first-page":"n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical Res ed). 2021;372:n71.","journal-title":"BMJ (Clinical Res ed)"},{"key":"6534_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2288-14-45","volume":"14","author":"CK Lo","year":"2014","unstructured":"Lo CK, Mertz D, Loeb M. Newcastle-Ottawa Scale: comparing reviewers\u2019 to authors\u2019 assessments. BMC Med Res Methodol. 2014;14:45.","journal-title":"BMC Med Res Methodol"},{"issue":"10","key":"6534_CR13","first-page":"Ed000142","volume":"10","author":"M Cumpston","year":"2019","unstructured":"Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, Thomas J. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10(10):Ed000142.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7109","key":"6534_CR14","first-page":"629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Res ed). 1997;315(7109):629\u201334.","journal-title":"BMJ (Clinical Res ed)"},{"issue":"1","key":"6534_CR15","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12933-024-02352-6","volume":"23","author":"W Li","year":"2024","unstructured":"Li W, Shen C, Kong W, Zhou X, Fan H, Zhang Y, Liu Z, Zheng L. Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with Cardiovascular-Kidney-Metabolic syndrome stage 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2024;23(1):292.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"6534_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12933-025-02842-1","volume":"24","author":"K Liu","year":"2025","unstructured":"Liu K, Hu J, Huang Y, He D, Zhang J. Triglyceride-glucose-related indices and risk of cardiovascular disease and mortality in individuals with cardiovascular-kidney-metabolic (CKM) syndrome stages 0\u20133: a prospective cohort study of 282,920 participants in the UK Biobank. Cardiovasc Diabetol. 2025;24(1):277.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"6534_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12933-025-02662-3","volume":"24","author":"J Hong","year":"2025","unstructured":"Hong J, Zhang R, Tang H, Wu S, Chen Y, Tan X. Comparison of triglyceride glucose index and modified triglyceride glucose indices in predicting cardiovascular diseases incidence among populations with cardiovascular-kidney-metabolic syndrome stages 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):98.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"6534_CR18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s13098-025-01919-x","volume":"17","author":"Y Pan","year":"2025","unstructured":"Pan Y, Du B, Feng L, Bi J. Comparative analysis of 16 baseline obesity and lipid-related indices for cardiovascular disease risk prediction in adults with cardiovascular-kidney-metabolic syndrome stages 0\u20133: a nationwide prospective cohort study. Diabetol Metab Syndr. 2025;17(1):343.","journal-title":"Diabetol Metab Syndr"},{"key":"6534_CR19","doi-asserted-by":"publisher","first-page":"112327","DOI":"10.1016\/j.diabres.2025.112327","volume":"226","author":"M Wang","year":"2025","unstructured":"Wang M, Lin W, Liu H, Qian ZM, Chen J, Rao M, Zhou Q, Zhuang Z, Luo L, Fang Y, et al. Associations between insulin resistance indices and cardiovascular disease in older adults with cardiovascular-kidney-metabolic syndrome stage 0\u20133: The GOLD-Health cohort. Diabetes Res Clin Pract. 2025;226:112327.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"6534_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s13098-025-01882-7","volume":"17","author":"J Chen","year":"2025","unstructured":"Chen J, Yan L, He L, Wang W. Association between different dimensions of the C-reactive protein-triglyceride-glucose index and future cardiovascular disease risk in individuals with cardiovascular-kidney-metabolic syndrome stages 0\u20133: a nationwide cohort study. Diabetol Metab Syndr. 2025;17(1):299.","journal-title":"Diabetol Metab Syndr"},{"key":"6534_CR21","doi-asserted-by":"publisher","first-page":"1604270","DOI":"10.3389\/fcvm.2025.1604270","volume":"12","author":"C Huang","year":"2025","unstructured":"Huang C, Jia J, He Y. The nonlinear association between the triglyceride glucose-waist-to-height ratio index and cardiovascular disease among middle-aged and older adults in China with cardiovascular-kidney-metabolic syndrome stages 0\u20133. Front Cardiovasc Med. 2025;12:1604270.","journal-title":"Front Cardiovasc Med"},{"key":"6534_CR22","doi-asserted-by":"crossref","unstructured":"Han SS, Liu Q, Zhou MQ, Liu Y, Guo TT, Hu YK, Gao TA, Zeng ZM. Longitudinal associations of cumulative and repeated-measure patterns of insulin resistance surrogate indices with biological age acceleration and incident cardiovascular disease across cardiovascular-kidney-metabolic syndrome stages 0\u20133: evidence from CHARLS 2011\u20132020. Cardiovasc Diabetol. 2026;25(1):198.","DOI":"10.1186\/s12933-026-03206-z"},{"key":"6534_CR23","doi-asserted-by":"crossref","unstructured":"Wang K, Luo X, Wan D, Su B, Li Y. Associations of visceral fat accumulation with cardiovascular disease across cardiovascular-kidney-metabolic syndrome stages 0\u20133: mediation effects of arterial stiffness in a prospective cohort study. BMC Cardiovasc Disord. 2026;26(1):387.","DOI":"10.1186\/s12872-026-05775-z"},{"issue":"2","key":"6534_CR24","doi-asserted-by":"publisher","first-page":"102344","DOI":"10.1016\/j.cpcardiol.2023.102344","volume":"49","author":"SA Sebastian","year":"2024","unstructured":"Sebastian SA, Padda I, Johal G. Cardiovascular-Kidney-Metabolic (CKM) syndrome: A state-of-the-art review. Curr Probl Cardiol. 2024;49(2):102344.","journal-title":"Curr Probl Cardiol"},{"issue":"5","key":"6534_CR25","doi-asserted-by":"publisher","first-page":"147916412211362","DOI":"10.1177\/14791641221136203","volume":"19","author":"S \u00d6zbi\u00e7er","year":"2022","unstructured":"\u00d6zbi\u00e7er S, Y\u00fcksel G, Deniz Urgun \u00d6. Triglyceride glucose index is independently associated with aortic intima-media thickness in patients without known atherosclerotic cardiovascular disease or diabetes. Diabetes Vasc Dis Res. 2022;19(5):14791641221136203.","journal-title":"Diabetes Vasc Dis Res"},{"issue":"11","key":"6534_CR26","doi-asserted-by":"publisher","first-page":"e2445309","DOI":"10.1001\/jamanetworkopen.2024.45309","volume":"7","author":"R Zhu","year":"2024","unstructured":"Zhu R, Wang R, He J, Wang L, Chen H, Niu X, Sun Y, Guan Y, Gong Y, Zhang L, et al. Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages by Social Determinants of Health. JAMA Netw open. 2024;7(11):e2445309.","journal-title":"JAMA Netw open"},{"key":"6534_CR27","doi-asserted-by":"publisher","first-page":"1661563","DOI":"10.3389\/fcvm.2025.1661563","volume":"12","author":"J Nzobokela","year":"2025","unstructured":"Nzobokela J, Muchaili L, Mwambungu A, Masenga SK, Kirabo A. Pathophysiology and emerging biomarkers of cardiovascular-renal-hepato-metabolic syndrome. Front Cardiovasc Med. 2025;12:1661563.","journal-title":"Front Cardiovasc Med"},{"issue":"10","key":"6534_CR28","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1055\/a-2266-1503","volume":"56","author":"M Li","year":"2024","unstructured":"Li M, Cui M, Li G, Liu Y, Xu Y, Eftekhar SP, Ala M. The Pathophysiological Associations Between Obesity, NAFLD, and Atherosclerotic Cardiovascular Diseases. Hormone metabolic Res = Hormon- und Stoffwechselforschung = Horm et Metab. 2024;56(10):683\u201396.","journal-title":"Hormone metabolic Res = Hormon- und Stoffwechselforschung = Horm et Metab"},{"key":"6534_CR29","doi-asserted-by":"crossref","unstructured":"Mohammadian K, Basirian N, Fakhar F, Keramat S, Stanek A. Insulin Resistance and Platelet Hyperactivity: Hematological Insights and Nutritional Strategies for Vascular Protection. Nutrients. 2026;18(5):763.","DOI":"10.3390\/nu18050763"},{"issue":"1","key":"6534_CR30","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s12933-024-02518-2","volume":"23","author":"Y Yang","year":"2024","unstructured":"Yang Y, Li S, Ren Q, Qiu Y, Pan M, Liu G, Zheng R, An Z, Li S. The interaction between triglyceride-glucose index and visceral adiposity in cardiovascular disease risk: findings from a nationwide Chinese cohort. Cardiovasc Diabetol. 2024;23(1):427.","journal-title":"Cardiovasc Diabetol"},{"key":"6534_CR31","doi-asserted-by":"crossref","unstructured":"Chu X, Niu H, Wang N, Wang Y, Xu H, Wang H, Wu L, Li W, Han L. Triglyceride-Glucose-Based Anthropometric Indices for Predicting Incident Cardiovascular Disease: Relative Fat Mass (RFM) as a Robust Indicator. Nutrients. 2025;17(13):2212.","DOI":"10.3390\/nu17132212"},{"issue":"1","key":"6534_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000547533","volume":"15","author":"Z Fang","year":"2025","unstructured":"Fang Z, Yuan J, Qiu J, Liu Q, He R, Zheng D, Jin J, He Q. Association between visceral lipid accumulation indicators and advanced cardiovascular-kidney-metabolic syndrome: a cross-sectional study based on NHANES 1999\u20132018. Cardiorenal Med. 2025;15(1):1\u201330.","journal-title":"Cardiorenal Med"},{"issue":"1","key":"6534_CR33","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12889-025-25830-2","volume":"26","author":"T Wang","year":"2025","unstructured":"Wang T, Zhang L, Chen P, Chen C, Xu L, Guo M. Weight-adjusted waist index outperforms other obesity indices for cardiovascular disease prediction in cardiovascular-kidney-metabolic syndrome: insights from UK biobank. BMC Public Health. 2025;26(1):160.","journal-title":"BMC Public Health"},{"issue":"9","key":"6534_CR34","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1016\/j.ekir.2024.05.033","volume":"9","author":"ZA Massy","year":"2024","unstructured":"Massy ZA, Drueke TB. Combination of Cardiovascular, Kidney, and Metabolic Diseases in a Syndrome Named Cardiovascular-Kidney-Metabolic, With New Risk Prediction Equations. Kidney Int Rep. 2024;9(9):2608\u201318.","journal-title":"Kidney Int Rep"},{"issue":"2","key":"6534_CR35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1023\/A:1010335505357","volume":"24","author":"FM Platt","year":"2001","unstructured":"Platt FM, Jeyakumar M, Andersson U, Priestman DA, Dwek RA, Butters TD, Cox TM, Lachmann RH, Hollak C, Aerts JM, et al. Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy. J Inherit Metab Dis. 2001;24(2):275\u201390.","journal-title":"J Inherit Metab Dis"},{"key":"6534_CR36","doi-asserted-by":"crossref","unstructured":"Mutruc V, Bologa C, \u0218orodoc V, Ceasovschih A, Mor\u0103ra\u0219u BC, \u0218orodoc L, Catar OE, Lionte C. Cardiovascular-Kidney-Metabolic Syndrome: A New Paradigm in Clinical Medicine or Going Back to Basics? J Clin Med. 2025;14(8):2833.","DOI":"10.3390\/jcm14082833"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06534-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06534-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06534-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:21:02Z","timestamp":1791289262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06534-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6534"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06534-w","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"assertion":[{"value":"17 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"880"}}